EU Medical Device Market Access: EU Authorised Representative

Entering the European Union market with a medical device requires more than just innovation and quality. Foreign manufacturers must navigate complex regulatory requirements under Regulation (EU) 2017/745, known as the EU Medical Device Regulation (MDR). This regulation ensures that medical devices meet high safety and performance standards before they reach patients and healthcare providers in the EU.

This blog explains the key steps for placing medical devices on the EU market, the role of the EU Authorised Representative, and how AF Pharma supports manufacturers with regulatory compliance and market access.

Medical device packaging showing CE marking label

Understanding MDR 2017/745 and Its Impact on Market Access

The EU MDR 2017/745 replaced the previous Medical Device Directive to strengthen the regulatory framework for medical devices in Europe. It applies to all medical devices, including software and accessories, placed on the EU market.

Foreign manufacturers must comply with MDR 2017/745 before marketing their devices in the EU. This means:

• Correct device classification: Devices are classified into Classes I, IIa, IIb, or III based on risk. Classification determines the conformity assessment route.

• Conformity assessment: Depending on classification, manufacturers must undergo assessment by a notified body or self-certify for low-risk devices.

• Technical documentation: Comprehensive documentation must demonstrate compliance, including design, manufacturing, and safety data.

• Clinical evaluation report: Manufacturers must provide clinical evidence supporting device safety and performance.

• Risk management: A risk management system must identify and control risks throughout the device lifecycle.

• Post-market surveillance (PMS): Ongoing monitoring of device performance and safety after market launch is mandatory.

• Labelling and Instructions for Use (IFU): Labels and IFUs must meet MDR requirements, including language and content.

• Unique Device Identification (UDI): Devices require UDI codes to improve traceability and safety.

  
  

Meeting these requirements ensures devices are safe, effective, and compliant with EU law.

The Essential Role of the EU Authorised Representative

Non-EU manufacturers cannot place medical devices on the EU market without appointing an EU Authorised Representative (EU AR). This representative must be established within the European Union and acts as the official regulatory contact point.

The EU Authorised Representative’s responsibilities include:

• Regulatory liaison: Communicating with EU competent authorities on behalf of the manufacturer.

• Documentation verification: Ensuring the required MDR technical documentation is complete and accessible.

• Incident reporting support: Assisting with vigilance and post-market safety reporting.

• Ongoing compliance: Helping manufacturers maintain MDR compliance through updates and audits.

  
  

Without an EU Authorised Representative, foreign manufacturers cannot legally market their devices in the EU. This role is critical for smooth regulatory processes and market access.

How AF Pharma Supports Your EU Medical Device Registration

AF Pharma offers expert regulatory consulting tailored to manufacturers, startups, and SMEs aiming for medical device EU market access. Our services cover every step of MDR compliance and registration, including:

• Acting as your EU Authorised Representative to handle regulatory communications and documentation.

• Reviewing and preparing MDR technical documentation to meet notified body and authority expectations.

• Supporting the development of your clinical evaluation report with scientific and regulatory expertise.

• Assisting with PMS medical device plans and reporting to ensure ongoing safety monitoring.

• Conducting thorough medical device label review and IFU checks to comply with MDR requirements.

• Advising on UDI strategy implementation for device traceability.

• Providing guidance on EUDAMED registration and database management.

  
  

Our practical approach helps you avoid common pitfalls and accelerates your path to CE marking medical device approval.

Practical Steps to Prepare for EU Medical Device Market Access

To successfully place your device on the EU market, follow these key steps:

1. Determine device classification based on MDR rules.

2. Engage a notified body if your device requires third-party conformity assessment.

3. Compile technical documentation covering design, manufacturing, clinical data, and risk management.

4. Develop a clinical evaluation report using clinical data and literature.

5. Set up a PMS system to monitor device performance post-market.

6. Prepare compliant labels and IFUs in required EU languages.

7. Implement UDI codes and register devices in EUDAMED.

8. Appoint an EU Authorised Representative to manage regulatory obligations within the EU.

   
   

Each step requires attention to detail and regulatory knowledge to avoid delays or non-compliance.

Why Choose AF Pharma EU Rep Services

Navigating the EU MDR landscape can be challenging, especially for manufacturers outside the EU. AF Pharma brings deep regulatory experience and a client-focused approach to support your success. We provide:

• Clear guidance on MDR 2017/745 requirements.

• Hands-on support with documentation and clinical evaluation.

• Reliable EU Authorised Representative services ensuring regulatory compliance.

• Assistance with EUDAMED registration and post-market activities.

• Customized solutions for startups and SMEs with limited regulatory resources.

  
  

Partnering with AF Pharma means you gain a trusted regulatory expert committed to helping your medical device reach the European market efficiently and compliantly.

For manufacturers ready to expand into the EU, understanding MDR compliance and appointing a qualified EU Authorised Representative is essential. AF Pharma offers the expertise and services you need to meet these requirements confidently.